Health Benefits and Cost Effectiveness of Endoscopic and Nonendoscopic Cytosponge Screening for Barrett's Esophagus
- 31 January 2013
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 144 (1), 62-73.e6
- https://doi.org/10.1053/j.gastro.2012.09.060
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Adherence to Colorectal Cancer ScreeningJAMA Internal Medicine, 2012
- Durability of Radiofrequency Ablation in Barrett's Esophagus With DysplasiaGastroenterology, 2011
- Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based StudyJNCI Journal of the National Cancer Institute, 2011
- Trends in Hospital Volume and Operative Mortality for High-Risk SurgeryThe New England Journal of Medicine, 2011
- Biomarkers in Exploring the Frontiers of Diagnosis, Prognosis, and Therapy of Barrett's EsophagusCancer Prevention Research, 2011
- Performance measures in three rounds of the English bowel cancer screening pilotGut, 2011
- Dynamic Microsimulation Models for Health OutcomesMedical Decision Making, 2010
- Age- and sex-specific yield of Barrett's esophagus by endoscopy indicationGastrointestinal Endoscopy, 2010
- Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort studyGut, 2009
- Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort studyGut, 2007